Paul A Friedman's Net Worth
Paul A Friedman's net worth is estimated to be at least $89,063,581.36 as of 05/10/2024. CoreStreet's estimation of Paul A Friedman's net worth is based on their sale of stock and current holding of stock.
Paul A Friedman is Director at Madrigal Pharmaceuticals Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 26,270 units of MDGL stock on 04/08/2024. Their biggest sale was on 05/27/2015 when they sold 196,751 units of Incyte Corporation stock for $21,097,609.73. They typically trade 1 times per year.
Total value of insider buys:
- $520,930.00
Total value of insider sells:
- $88,542,651.36
Most recent insider trade:
- April 8, 2024
Paul A Friedman's Insider Trading History
| Madrigal Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 8, 2024 | Director | 26,270 | $246.19 | Sell | $6,467,411.30 |
April 4, 2024 | Director | 18,710 | $242.96 | Sell | $4,545,781.60 |
Nov. 19, 2018 | CEO | 4,000 | $124.00 | Buy | $496,000.00 |
| Incyte Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 6, 2019 | Director | 100,000 | $82.69 | Sell | $8,269,000.00 |
Nov. 16, 2017 | Director | 28,507 | $105.24 | Sell | $3,000,076.68 |
March 17, 2017 | Director | 50,000 | $148.72 | Sell | $7,436,000.00 |
May 27, 2015 | Director | 196,751 | $107.23 | Sell | $21,097,609.73 |
May 22, 2015 | Director | 102,243 | $108.22 | Sell | $11,064,737.46 |
Nov. 6, 2014 | Director | 185,653 | $67.87 | Sell | $12,600,269.11 |
Sept. 10, 2013 | CEO | 376,789 | $37.32 | Sell | $14,061,765.48 |
| Verastem Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 24, 2014 | Director | 3,000 | $8.31 | Buy | $24,930.00 |